Abstract
The present study describes the Bi (III) chloride catalyzed transformation of 4'-hydroxy-3',5'-dinitrochalcones into the corresponding benzoxazepines followed by sequential Michael addition using Bi (III) oxychloride as a procatalyst efficiently.
Keywords: Benzoxazepines, pro-catalyst, chalcones, Michael addition.
Letters in Organic Chemistry
Title:BiOCl Pro-Catalyzed Synthesis of Benzoxazepines from 4'-Hydroxy-3', 5'- Dinitro Substituted Chalcones and Ortho-Aminophenol
Volume: 11 Issue: 2
Author(s): K. L. Ameta
Affiliation:
Keywords: Benzoxazepines, pro-catalyst, chalcones, Michael addition.
Abstract: The present study describes the Bi (III) chloride catalyzed transformation of 4'-hydroxy-3',5'-dinitrochalcones into the corresponding benzoxazepines followed by sequential Michael addition using Bi (III) oxychloride as a procatalyst efficiently.
Export Options
About this article
Cite this article as:
Ameta L. K., BiOCl Pro-Catalyzed Synthesis of Benzoxazepines from 4'-Hydroxy-3', 5'- Dinitro Substituted Chalcones and Ortho-Aminophenol, Letters in Organic Chemistry 2014; 11 (2) . https://dx.doi.org/10.2174/1570178611310000090
DOI https://dx.doi.org/10.2174/1570178611310000090 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
New Strategies for Managing Anemia of Chronic Kidney Disease
Cardiovascular & Hematological Agents in Medicinal Chemistry HER2-Mediated Anticancer Drug Delivery: Strategies to Prepare Targeting Ligands Highly Specific for the Receptor
Current Medicinal Chemistry Natural Products as PI3K/ Akt Inhibitors: Implications in Preventing Hepatocellular Carcinoma
Current Molecular Pharmacology Exploration of the Medicinal Peptide Space
Protein & Peptide Letters P2Y Receptors in the Mammalian Nervous System: Pharmacology, Ligands and Therapeutic Potential
CNS & Neurological Disorders - Drug Targets Tumor Immune Escape Mechanisms that Operate During Metastasis
Current Pharmaceutical Biotechnology Inflammation, Serotonin and Major Depression
Current Drug Targets Natural Terpenoids Against Female Breast Cancer: A 5-year Recent Research
Current Medicinal Chemistry An Update of Radiolabeled Bombesin Analogs for Gastrin-Releasing Peptide Receptor Targeting
Current Pharmaceutical Design The Anticancer Properties of Dietary Polyphenols and its Relation with Apoptosis
Current Pharmaceutical Design mTOR Targeted Cancer Chemoprevention by Flavonoids
Current Medicinal Chemistry Synthesis of Combretastatin A-4 Analogs and their Biological Activities
Anti-Cancer Agents in Medicinal Chemistry MicroRNA-21 as Therapeutic Target in Cancer and Cardiovascular Disease
Recent Patents on Cardiovascular Drug Discovery New Insights on the Antitumoral Properties of Prodiginines
Current Medicinal Chemistry Peroxisome Proliferator-Activated Receptors and their Ligands in Cancer Drug- Resistance: Opportunity or Challenge
Anti-Cancer Agents in Medicinal Chemistry Extra-telomeric Functions of Human Telomerase: Cancer, Mitochondria and Oxidative Stress
Current Pharmaceutical Design Imaging Drug Resistance with Radiolabeled Molecules
Current Pharmaceutical Design Inhibitors of the Immunoproteasome: Current Status and Future Directions
Current Pharmaceutical Design Omega-3 Fatty Acid Treatment Combined with Chemotherapy to Prevent Toxicity, Drug Resistance, and Metastasis in Cancer
Current Drug Targets Overview of Angiogenesis and the use of Bevacizumab in Patients with Malignant Gliomas
Current Signal Transduction Therapy